Moderna, Pfizer, BioNTech Clash in UK Court Over COVID-19 Vaccine Patents
The legal battle in London's High Court centers on Moderna’s claims of patent infringement by Pfizer and BioNTech, with significant implications for future mRNA technology applications.
- Moderna accuses Pfizer and BioNTech of infringing on its mRNA technology patents, crucial for COVID-19 vaccine development.
- Pfizer and BioNTech counter by questioning the validity of Moderna’s patents, alleging they are improvements on prior work.
- The London trial is part of broader global litigation involving the companies in the US, Germany, and other jurisdictions.
- Financial stakes are high, with billions in vaccine sales potentially affected by the court's decision.
- Moderna seeks damages but not a halt in the use of Pfizer/BioNTech’s Comirnaty vaccine, acknowledging public health needs.
Benzinga 
Evening Standard 